tiprankstipranks
Advertisement
Advertisement

TENX Stock Latest News

Tenax Therapeutics price target raised to $50 from $20 at Piper Sandler
The FlyTenax Therapeutics price target raised to $50 from $20 at Piper Sandler
21h ago
TENX
Tenax Therapeutics Announces Results of 2026 Annual Meeting
PremiumCompany Announcements
Tenax Therapeutics Announces Results of 2026 Annual Meeting
9d ago
8K
TENX
Tenax Therapeutics: Buy Rating Reiterated with $27 Price Target Unchanged on Compelling Phase 3 Opportunity
PremiumRatings
Tenax Therapeutics: Buy Rating Reiterated with $27 Price Target Unchanged on Compelling Phase 3 Opportunity
1M ago
TENX
Tenax Therapeutics reports Q1 EPS (35c), consensus (40c)
PremiumThe Fly
Tenax Therapeutics reports Q1 EPS (35c), consensus (40c)
1M ago
TENX
Tenax Therapeutics appoints Timothy Healey as chief commercial officer
PremiumThe Fly
Tenax Therapeutics appoints Timothy Healey as chief commercial officer
1M ago
TENX
Tenax Therapeutics Names New CFO to Support Growth
PremiumCompany AnnouncementsTenax Therapeutics Names New CFO to Support Growth
2M ago
8K
TENX
Four new option listings on March 25th
Premium
The Fly
Four new option listings on March 25th
3M ago
IPX
SUNC
Tenax Therapeutics files $300M mixed securities shelf
Premium
The Fly
Tenax Therapeutics files $300M mixed securities shelf
3M ago
TENX
DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
PremiumThe Fly
DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
3M ago
LI
AJG
Cantor starts Tenax at Overweight into Phase 3 readout
PremiumThe Fly
Cantor starts Tenax at Overweight into Phase 3 readout
3M ago
TENX
Tenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Tenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
3M ago
TENX
Tenax Therapeutics price target raised to $34 from $25 at Guggenheim
PremiumThe Fly
Tenax Therapeutics price target raised to $34 from $25 at Guggenheim
3M ago
TENX
Tenax Therapeutics initiated with an Outperform at LifeSci Capital
PremiumThe FlyTenax Therapeutics initiated with an Outperform at LifeSci Capital
3M ago
TENX
Tenax Therapeutics reports Q4 EPS (38c), consensus (41c)
Premium
The Fly
Tenax Therapeutics reports Q4 EPS (38c), consensus (41c)
3M ago
TENX
Tenax Extends Phase 3 TNX-103 Study, Signaling Long-Term Bet on Pulmonary Hypertension Franchise
Premium
Company Announcements
Tenax Extends Phase 3 TNX-103 Study, Signaling Long-Term Bet on Pulmonary Hypertension Franchise
4M ago
TENX
Tenax Therapeutics Updates Chief Medical Officer Agreement
PremiumCompany Announcements
Tenax Therapeutics Updates Chief Medical Officer Agreement
5M ago
8K
TENX
Optimistic Outlook on Tenax Therapeutics: Buy Rating Backed by Promising Clinical Developments
PremiumRatings
Optimistic Outlook on Tenax Therapeutics: Buy Rating Backed by Promising Clinical Developments
6M ago
TENX
Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
PremiumCompany Announcements
Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
6M ago
TENX
Tenax Therapeutics reports result of prespecified blinded sample size assessment
PremiumThe Fly
Tenax Therapeutics reports result of prespecified blinded sample size assessment
6M ago
TENX
Tenax Therapeutics price target raised to $25 from $14 at Guggenheim
PremiumThe FlyTenax Therapeutics price target raised to $25 from $14 at Guggenheim
6M ago
TENX
Tenax Therapeutics to hold a conference call
Premium
The Fly
Tenax Therapeutics to hold a conference call
7M ago
TENX
Tenax Therapeutics Reports Increased R&D Expenses Amid Clinical Trials
Premium
Company Announcements
Tenax Therapeutics Reports Increased R&D Expenses Amid Clinical Trials
7M ago
TENX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >